经导管射频消融去肾交感神经术的作用机制及临床应用进展
摘要
高血压是最常见的慢性疾病之一,被认为是一个由多种病因引起的处于不断进展状态的心血管综合征,可导致心脏和血管功能与结构的改变。尤其是难治性高血压,患者在生活方式改善的基础上规律服用3种或3种以上足量的不同作用机制的降压药物(其中之一为利尿剂),血压仍不能达标,往往导致多种并发症的发生,预后极差。
出处
《中国医药》
2014年第11期1715-1717,共3页
China Medicine
基金
湖南省科学技术厅科技计划重点项目(2012WK2002)
参考文献18
-
1Lobodzinski SS. New developments in the treatment of severe drug resistant hypertension [ J ]. Cardiol J, 2011,18 (6) :707-711.
-
2Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a muhicentre safety and proof-of-principle cohort study [ J ]. Lancet, 2009, 373(9671 ) :1275-1281.
-
3Burns J, Sivananthan MU, Ball SG, et al. Relationship between central sympathetic drive and magnetic resonance imaging-deter- mined left ventricular mass in essential hypertension [ J ]. Circula- tion, 2007,115 ( 15 ) : 1999-2005.
-
4Wyss JM, Carlson SH. The role of the central nervous system in hypertension[ J]. Curt" Hypertens Rep, 1999,1 (3) :246-253.
-
5McBryde FD, Guild SJ, Barrett CJ, et al. Angiotensin II-based hypertension and the sympathetic nervous system: the role of dose and increased dietary salt in rabbits [ J ]. Exp Pbysiol, 2007, 92(5) :831-840.
-
6Smithwick RH. Hypertensive vascular disease:results of and indi- cations for splanchnicectomy [ J]. J Chronic Dis, 1955, 11 (5) : 477 -496.
-
7Grimson KS, Orgain ES, Anderson B, et al. Total thoracic and partial to total lumbar sympathectomy, splanchnicectomy and celi- ac ganglionectomy for hypertension [ J ]. Ann Surg, 1953, 138(4) :532-547.
-
8Schlaich MP, Krum H, Sobotka PA, et al. Renal denervation and hypertension [ J ]. Am J Hypertens, 2011,24 ( 6 ) :635.-642.
-
9Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months [ J ]. Hypertension, 2011,57 ( 5 ) :911 - 917.
-
10Syrnplicity HTN-2 Investigators, Esler MD, Krum H, et al. Renal sympathetic denervation in patients with treatment -resistant hy- pertension (The Symplicity HTN-2 Trial) :a randomised controlled trial[ J]. Lancet, 2010,376(9756) : 1903-1909.
二级参考文献96
-
1韩雅玲,王守力,李毅,荆全民,马颖艳,王祖禄,王冬梅,栾波,王效增.急性冠状动脉综合征患者冠状动脉支架术前高负荷量氯吡格雷预治疗近期疗效[J].中国介入心脏病学杂志,2005,13(1):9-12. 被引量:53
-
2Pfisterer M, Brunner La Rocca H P, Buser P T, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents [ J ]. J Am Coil Cardiol, 2006,48(12) :2584-2591.
-
3Mauri L, Hsieh W H, Massaro J M, et al. Stent throm- bosis in randomized clinical trials of drug-eluting stents [J]. N Engl J Med, 2007,356(10):1020-1029.
-
4Park S J, Lee C W, Kim Y H, et al. Technical feasibili- ty, safety, and clinical outcome of stenting of unprotected left main coronary artery bifurcation narrowing[ J]. Am J Cardiol, 2002,90:374-378.
-
5Seung K B, Park D W, Kim Y H, et al. Stents versus coronary artery bypass grafting for left main coronary ar- tery disease[ J ]. N Engl J Med, 2008,358 (17) : 1781- 1792.
-
6Serruys P W, Morice M C, Kappetein A P, et al. Pereu- taneous coronary intervention versus coronary artery by- pass grafting for severe coronary artery disease[ J]. N En- gl J Med, 2009,360(10) :961-972.
-
7Park S J, Kim Y H, Park D W, et al. Randomized trial of stents versus bypass surgery for left main coronary ar- tery disease[J]. N Engl J Med, 2011,364(18) :1718- 1727.
-
8Daemen J, Boersma E, Flather M, et al. Long term safe- ty and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5 year patient level data from the ARTS, ERACI-Ⅱ, MASS-Ⅱ, and SoS trials[J]. Circulation, 2008,118(11): 1146- 1154.
-
9Young J J, Cox D A, Stuckey T, et al. Prospective mul- ticenter study of thrombectomy in patients with acute myo- cardial infarction: the X-Tract AMI registry [ J]. J Interv Cardiol, 2007,20( 1 ) :44-50.
-
10Vlaar P J, Svilaas T, van D H, et al. Cardiac death and reinfaretion after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study ( TAPAS ) : a 1 -year follow-up study [ J ].Lancet, 2008,371(9628):1915-1920.
共引文献190
-
1谭国柱,卢允健,叶发卓.石决牡蛎汤联合氯沙坦治疗难治性高血压的临床观察[J].慢性病学杂志,2023(10):1555-1558.
-
2陈丽霞.电耳针联合西药治疗顽固性高血压的临床观察[J].内蒙古中医药,2023,42(2):67-70. 被引量:1
-
3刘立立,张伶俐,曾力楠,张川.卡维地洛联合螺内酯治疗难治性高血压的系统评价[J].医药导报,2015,34(S01):141-144. 被引量:11
-
4陈健.基层医院难治性高血压临床分析[J].医学信息(医学与计算机应用),2016,29(25):245-245.
-
5蒋阳,胡耀琪,唐娟.老年非透析慢性肾脏病合并高血压患者难治性高血压的影响因素[J].中国老年学杂志,2014,34(11):3020-3022. 被引量:14
-
6孙秀云,吴涛,路孝琴,崔树起,张冬梅,孙中华,郭爱民.北京市原崇文区正常高值血压流行现状及影响因素分析[J].首都医科大学学报,2013,34(1):130-133. 被引量:3
-
7孔冬梅,王新宴,陈红,赵成炫,张建玲.冠心病患者动脉弹性及血管负荷指数情况变化研究[J].海南医学院学报,2013,19(3):314-316. 被引量:1
-
8李群华.单硝酸异山梨酯、卡托普利与呋塞米联合治疗扩张性心肌病心力衰竭[J].中国现代医生,2013,51(5):132-133. 被引量:3
-
9王茜,李兴朝,闵新文,李东锋,朗明建.血清hs-CRP水平对急性心肌梗死PCI术后亚急性支架内血栓形成的预测价值[J].海南医学院学报,2013,19(8):1042-1044. 被引量:12
-
10孙宁玲.难治性高血压的诊治、评估简易流程[J].心脑血管病防治,2013,13(4):259-260.
-
1肖戈.慢性阻塞性肺疾病急性加重期的营养支持疗效观察[J].内蒙古中医药,2013,32(34):21-21. 被引量:2
-
2胡翠芬,周少坤,龙莹,杨艺,蔡思宇.心血管疾病防治中血压管理的新认识[J].心电与循环,2015,34(1):57-59. 被引量:1
-
3王文俊.地方性克汀病中长期甲状腺功能低下对垂体功能与结构的影响[J].地方病译丛,1990,11(4):42-43.
-
4高血压病人代谢综合征对左室功能与结构的影响[J].中华高血压杂志,2006,14(11):942-942.
-
5黎玉冰,陈丽彩,周保玲.认知行为干预对慢性阻塞性肺疾病患者自我护理能力及生活方式的影响[J].护理实践与研究,2016,13(3):156-158. 被引量:14
-
6于波.肾动脉交感神经射频消融治疗顽固性高血压[J].中华医学信息导报,2014,0(22):18-18.
-
7汪婷,丛培玲,孙晓斐.二甲双胍对糖耐量减低冠心病患者干预后的临床观察[J].济宁医学院学报,2011,34(2):114-115. 被引量:2
-
8周斌.雷米普利治疗原发性高血压的临床观察[J].实用糖尿病杂志,2008,4(4):58-59. 被引量:1
-
9史岩.高血压病患者健康生活方式[J].现代保健(医学创新研究),2008,5(8):173-173. 被引量:1
-
10三浦傅,杜军.缺血性心脏病与饮食生活方式改善[J].日本医学介绍,2003,24(2):61-63.